REVIEW ON ANTI-PARKINSONS DRUGS

Authors

  • Mr.Janardhan Gangadharrao Bhure
  • Shaikh Alim Ahemadsab
  • Miss. Vaishnavi Vasantrao Khandre
  • Dr.syed Ansar Ahmed
  • Mr.Rohit shivprasad Muneshwar
  • Madhav Chandrao Dakhore

DOI:

https://doi.org/10.53555/9vatea52

Keywords:

Parkinson’s disease, treatment, motor and non-motor symptoms, Anti-Parkinson’s drugs

Abstract

This review the discussion was about the prevalence, awareness, diagnosis, treatment, and control of Parkinson's disease in older adults. Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older adults Resulting from a pathophysiologic loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain and the development of neuronal Lewy Bodies, idiopathic Parkinson's Disease is associated with risk factors including aging, family history, pesticide exposure and environmental chemicals (e.g., synthetic heroin use). Its ultimate cause(s) is (are) unknown.Characterized by both motor and non-motor symptoms, PD patients classically display rest tremor, Muscular rigidity, Loss of associated movements, hypokinesia, etc.

Author Biographies

  • Mr.Janardhan Gangadharrao Bhure
    Assistant professor (Dept. Of pharmacology). Department of pharmacology ,Sahyog education society's indira college of pharmacy, Nanded.  
  • Shaikh Alim Ahemadsab
    Lecturer SLSA pharmacy college, khandgaon(Kh.) ,Mukhed.  
  • Miss. Vaishnavi Vasantrao Khandre
    Assistant Professor (pharmacology) Department of pharmacology, Sahayog education society's Indira college of pharmacy, Nanded.
  • Dr.syed Ansar Ahmed
    Associate professor (Dept.Of pharmaceutical chemistry.) Department of pharmaceutical chemistry, Sahayog education society's Indira college of pharmacy, Nanded.
  • Mr.Rohit shivprasad Muneshwar
    Assistant professor (Dept. Of pharmaceutics).Department of pharmaceutics ,Sahyog education society's indira college of pharmacy, Nanded.
  • Madhav Chandrao Dakhore
    Associate professor (Dept.Of pharmaceutical chemistry.) Department of pharmaceutical chemistry, Sahayog education society's Indira college of pharmacy, Nanded.

References

1. National Institute for Health and Clinical Excellence, Parkinson's disease: Diagnosis and Management in Primary and Secondary Care, 2006LondonNICE

2. Bhure, Mr Janardhan G., Mr Navab S. Pinjari, and Omkar S. Suryawanshi. "Review On Anti-Hypertensive Agents." Journal of Survey in Fisheries Sciences (2023): 4324-4330.

3. Betarbet R, Sherer TB, Greenamyre JT. Ubiquitin-proteasome system and Parkinson's diseases, ExpNeurol, 2005, vol. 191 (Suppl 1)(pg. 17-27) R

4. Rang & Dale's pharmacology.

5. KD Tripathi. In his book (essential of medical pharmacology)

6. Amos D. Korczyn, ... Tanya Gurevich, in International Encyclopedia of Public Health (Second Edition), 2017

7. Beitz JM. Parkinson's disease: a review. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. PMID: 24389262.

Downloads

Published

2023-01-24

How to Cite

Mr.Janardhan Gangadharrao Bhure, Shaikh Alim Ahemadsab, Miss. Vaishnavi Vasantrao Khandre, Dr.syed Ansar Ahmed, Mr.Rohit shivprasad Muneshwar, & Madhav Chandrao Dakhore. (2023). REVIEW ON ANTI-PARKINSONS DRUGS. Journal of Population Therapeutics and Clinical Pharmacology, 30(1), 8041-8048. https://doi.org/10.53555/9vatea52
More Citation Formats

Issue

Section

Articles

How to Cite

Mr.Janardhan Gangadharrao Bhure, Shaikh Alim Ahemadsab, Miss. Vaishnavi Vasantrao Khandre, Dr.syed Ansar Ahmed, Mr.Rohit shivprasad Muneshwar, & Madhav Chandrao Dakhore. (2023). REVIEW ON ANTI-PARKINSONS DRUGS. Journal of Population Therapeutics and Clinical Pharmacology, 30(1), 8041-8048. https://doi.org/10.53555/9vatea52